Follow
James Yu
James Yu
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
SB Goldberg, SN Gettinger, A Mahajan, AC Chiang, RS Herbst, M Sznol, ...
The lancet oncology 17 (7), 976-983, 2016
9752016
Management of brain metastases in tyrosine kinase inhibitor–na´ve epidermal growth factor receptor–mutant non–small-cell lung cancer: a retrospective multi-institutional analysis
WJ Magnuson, NH Lester-Coll, AJ Wu, TJ Yang, NA Lockney, NK Gerber, ...
Journal of clinical oncology 35 (10), 1070-1077, 2017
4172017
A retrospective review of 1349 cases of sebaceous carcinoma
T Dasgupta, LD Wilson, JB Yu
Cancer 115 (1), 158-165, 2009
3682009
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
JPS Knisely, BY James, J Flanigan, M Sznol, HM Kluger, VLS Chiang
Journal of neurosurgery 117 (2), 227-233, 2012
3432012
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Y Lievens, M Guckenberger, D Gomez, M Hoyer, P Iyengar, I Kindts, ...
Radiotherapy and Oncology 148, 157-166, 2020
3352020
Extended survival and prognostic factors for patients with ALK-rearranged non–small-cell lung cancer and brain metastasis
KL Johung, N Yeh, NB Desai, TM Williams, T Lautenschlaeger, ND Arvold, ...
Journal of Clinical Oncology 34 (2), 123, 2016
3292016
The inhibin/activin family of hormones and growth factors
W Vale, A Hsueh, C Rivier, J Yu
Peptide growth factors and their receptors II, 211-248, 1990
3251990
Use of alternative medicine for cancer and its impact on survival
SB Johnson, HS Park, CP Gross, JB Yu
JNCI: Journal of the National Cancer Institute 110 (1), 121-124, 2018
3062018
Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers
SB Johnson, HS Park, CP Gross, BY James
JAMA oncology 4 (10), 1375-1381, 2018
2982018
Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation
SL Galper, JB Yu, PM Mauch, JF Strasser, B Silver, A LaCasce, ...
Blood, The Journal of the American Society of Hematology 117 (2), 412-418, 2011
2812011
Long-term survival of patients with melanoma with active brain metastases treated with pembrolizumab on a phase II trial
HM Kluger, V Chiang, A Mahajan, CR Zito, M Sznol, T Tran, SA Weiss, ...
Journal of Clinical Oncology 37 (1), 52, 2019
2282019
Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
RJ Colaco, P Martin, HM Kluger, BY James, VL Chiang
Journal of neurosurgery 125 (1), 17-23, 2016
2232016
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery
JM Qian, JB Yu, HM Kluger, VLS Chiang
Cancer 122 (19), 3051-3058, 2016
2142016
Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance
CC Lin, SS Bruinooge, MK Kirkwood, C Olsen, A Jemal, D Bajorin, ...
Journal of Clinical Oncology 33 (28), 3177, 2015
2092015
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity
JB Yu, PR Soulos, J Herrin, LD Cramer, AL Potosky, KB Roberts, ...
Journal of the National Cancer Institute 105 (1), 25-32, 2013
2032013
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity
JB Yu, PR Soulos, J Herrin, LD Cramer, AL Potosky, KB Roberts, ...
Journal of the National Cancer Institute 105 (1), 25-32, 2013
2032013
Prostate cancer radiation therapy recommendations in response to COVID-19
NG Zaorsky, BY James, SM McBride, RT Dess, WC Jackson, BA Mahal, ...
Advances in radiation oncology 5, 26-32, 2020
1782020
Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA)
PW Sperduto, W Jiang, PD Brown, S Braunstein, P Sneed, DA Wattson, ...
International Journal of Radiation Oncology* Biology* Physics 99 (4), 812-816, 2017
1782017
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a surveillance, epidemiology, and end results analysis
DL Buscariollo, HS Park, KB Roberts, JB Yu
Cancer 118 (17), 4212-4219, 2012
1762012
Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity
BY James, LD Cramer, J Herrin, PR Soulos, AL Potosky, CP Gross
Journal of clinical oncology 32 (12), 1195, 2014
1642014
The system can't perform the operation now. Try again later.
Articles 1–20